Us Bancorp \De\ Royalty Pharma PLC Transaction History
Us Bancorp \De\
- $77.3 Billion
- Q3 2024
A detailed history of Us Bancorp \De\ transactions in Royalty Pharma PLC stock. As of the latest transaction made, Us Bancorp \De\ holds 3,806 shares of RPRX stock, worth $120,193. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,806
Previous 5,856
35.01%
Holding current value
$120,193
Previous $154,000
30.52%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding RPRX
# of Institutions
412Shares Held
282MCall Options Held
578KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.3 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.6MShares$1.19 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$727 Million0.01% of portfolio
-
Baillie Gifford & CO14.1MShares$446 Million0.28% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$384 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $13.8B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...